GL1X · GenesisL1 explorer

Research workbench

Pandda analysis group deposition -- crystal structure of SARS-cov-2 helicase in complex with Z85956652

Analyse Pandda analysis group deposition -- crystal structure of SARS-cov-2 helicase in… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5RML
Type
protein
Length
1,157 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Helicase
EC
3.6.4.12, 3.6.4.13
UniProt
P0DTD1
Ligands
VXD, ZN, PO4
Pockets
15 · best druggability 0.75

Structure

x-ray diffraction · 2 distinct chains · 29% helix, 23% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
BHelicase (EC 3.6.4.12, 3.6.4.13)protein58528% helix, 24% strandP0DTD1
AHelicase (EC 3.6.4.12, 3.6.4.13)protein57230% helix, 23% strandP0DTD1

Ligands and binding sites

  • VXD · N-(3-chloro-2-methylphenyl)glycinamide · ligand · chains A
  • ZN · Zinc ion · metal · 6 copies · chains B, A
  • PO4 · Phosphate ion · ion · 4 copies · chains B, A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

15 pockets found on a 1 Å grid, 8 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15670.750.8244VXD
22740.710.8541empty
34720.670.7954empty
42950.650.8139empty
51940.620.8328PO4

Interfaces

1 interface between chains.

  • B–A · 661 Ų buried · 5 hydrogen bonds · protein-protein

Compared structures

  • 5RML · PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex… · the same entry in another collection · chain B against B, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.